PROTAC technology for prostate cancer treatment
Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men. PrCa is marked by uncontrolled cellular growth that leads to abnormal enlargement of the prostate gland. The metastatic spread of PrCa is the primary cause of mortality, causing cancer cell dissemination to distant sites,...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Compuscript Ltd
2025-01-01
|
| Seria: | Acta Materia Medica |
| Dostęp online: | https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0075 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|